Page last updated: 2024-12-11
2-hydroxy-2,4-pentadienoic acid
Description
2-hydroxy-2,4-pentadienoic acid: structure given in first source; chemically unstable intermediate formed in catechol metabolism via meta cleavage in Pseudomonas putida [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
(2Z)-2-hydroxypenta-2,4-dienoic acid : A 2-hydroxypenta-2,4-dienoic acid in which the double bond between positions 2 and 3 has Z- (trans-) geometry. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]
Cross-References
| ID Source | ID |
|---|
| PubMed CID | 5459917 |
| CHEBI ID | 18355 |
| CHEBI ID | 48643 |
| SCHEMBL ID | 380795 |
| SCHEMBL ID | 468369 |
| MeSH ID | M0170914 |
Synonyms (11)
| Synonym |
|---|
| 50480-68-7 |
| 2-hydroxy-2,4-pentadienoic acid |
| CHEBI:18355 |
| CHEBI:48643 |
| (2z)-2-hydroxypenta-2,4-dienoic acid |
| AKOS006374424 |
| 2,4-pentadienoic acid, 2-hydroxy- |
| SCHEMBL380795 |
| SCHEMBL468369 |
| cis-2-hydroxy-penta-2,4-dienoic acid |
| Q27104619 |
Drug Classes (1)
| Class | Description |
|---|
| 2-hydroxypenta-2,4-dienoic acid | A 5-carbon, bis-unsaturated, alpha-hydroxy fatty acid metabolite of the proteobacterium substrate 2-hydroxy-6-oxo-6-phenylhexa-2,4-dienoic acid (HOPDA). |
| [compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] |
Research
Studies (5)
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|
| pre-1990 | 1 (20.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 12.76
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| Metric | This Compound (vs All) |
|---|
| Research Demand Index | 12.76 (24.57) | | Research Supply Index | 1.79 (2.92) | | Research Growth Index | 4.55 (4.65) | | Search Engine Demand Index | 0.00 (26.88) | | Search Engine Supply Index | 0.00 (0.95) |
| |
Study Types
| Publication Type | This drug (%) | All Drugs (%) |
|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 5 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |